Fertility warning
This medicine may affect fertility.
Leaflet CEENU 40mg soft capsules
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Lomustine is a chemotherapy medication used to treat certain types of cancer, including brain tumors, Hodgkin's lymphoma, and other advanced cancers. It belongs to the class of alkylating agents and works by damaging the DNA of cancer cells, preventing them from multiplying.
The medication is taken orally, usually in capsule form, and the dosage is adjusted based on body weight and the type of cancer being treated. Treatment is carried out under the strict supervision of an oncologist.
Side effects may include nausea, vomiting, decreased blood cell counts, fatigue, and an increased risk of infections. It is important for patients to be regularly monitored to assess the effectiveness of the treatment and manage any adverse reactions.
Pregnant or breastfeeding women should not use lomustine, and patients must inform their doctor about any other medications or supplements they are taking.
The medication is taken orally, usually in capsule form, and the dosage is adjusted based on body weight and the type of cancer being treated. Treatment is carried out under the strict supervision of an oncologist.
Side effects may include nausea, vomiting, decreased blood cell counts, fatigue, and an increased risk of infections. It is important for patients to be regularly monitored to assess the effectiveness of the treatment and manage any adverse reactions.
Pregnant or breastfeeding women should not use lomustine, and patients must inform their doctor about any other medications or supplements they are taking.
General data about CEENU 40mg
- Substance:
- lomustine
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W54014001
- Concentration:
- 40mg
- Pharmaceutical form:
- soft capsules
- Quantity:
- 20
- Product type:
- Generic medicine
- Prescription status:
- X